Indivior Pharmaceuticals, Inc. (INDV) has 4 SEC Form 4 insider filings on record in the last 90 days. That includes 2 insider purchases totalling $108K, and 1 sales totalling $765K. Most recent filing: Aug. 27, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 27, 2026 | Anderson Woodrow D Chief Accounting Officer | +$53,535 | 1,500 | +6% | No | |
|
|
||||||
| Aug. 5, 2026 | Anderson Woodrow D Chief Accounting Officer | +$54,420 | 1,500 | +6% | No | |
|
|
||||||
| July 13, 2026 filed July 10, 2026 | Heidbreder Christian Chief Scientific Officer | −$764,628 | 18,586 | −8% | Yes | |
|
|
||||||
| June 23, 2026 filed June 22, 2026 | Ciaffoni Joseph Chief Executive Officer | — | +654,354 | — | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free